DELVENIA TWON KILYOFAS
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CHESAPEAKE, VA NPI 1770087751
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family VA Otsuka America Pharmaceutical, Inc. All categories
General Payments — all program years on this page
$1,126.12
- Category: General Payments
- Program years: PY2023–2024
- Record count: 11
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $777.61 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $777.61 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $244.51 | 2 |
| Janssen Pharmaceuticals, Inc | $135.77 | 1 |
| E.R. Squibb & Sons, L.L.C. | $120.75 | 1 |
| ABBVIE INC. | $114.65 | 1 |
| Axsome Therapeutics, Inc. | $111.84 | 1 |
| CSL Behring | $25.09 | 1 |
| Novo Nordisk AS | $25.00 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078223313 | Janssen Pharmaceuticals, Inc | $135.77 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100264396 | Novo Nordisk Inc | $25.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101650895 | E.R. Squibb & Sons, L.L.C. | $120.75 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106832874 | ABBVIE INC. | $114.65 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119034105 | Otsuka America Pharmaceutical, Inc. | $120.51 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119034107 | Otsuka America Pharmaceutical, Inc. | $124.00 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1134624113 | CSL Behring | $25.09 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148353718 | Axsome Therapeutics, Inc. | $111.84 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.